Phase 1 Trial

Breaking Down Molly: Swiss University Studies How MDMA's Components Might Affect Humans
Codiak BioSciences' Engineered Exosome Candidates Show Early Antitumor Activity
eFFECTOR's Cancer Therapy Achieves Two Partial Responses In Early-Stage Study
Codiak BioSciences' Engineered Exosome Candidates Show Early Antitumor Activity
eFFECTOR's Cancer Therapy Achieves Two Partial Responses In Early-Stage Study
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
Keros Therapeutics Posts Preliminary Data Early-Stage KER-012 Trial

Phase 1 Trial Recent News

Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine
AbbVie - Genmab Post Epcoritamab Data From Early-Stage Blood Cancer Study
Genmab A/S (NASDAQ: GMAB) and AbbVie Inc (NYSE: ABBV) 
Cocrystal Pharma Posts Favorable Preliminary Data From Influenza A Antiviral Candidate Trial
Cocrystal Pharma Inc (NASDAQ: COCP) 
Repare Therapeutics Shares Dip After Updated RP-3500 Data In Solid Tumors
FDA Approves BioCardia's Phase 1 Trial With Cell Therapy In COVID-19, Shares Jump
IO Biotech Reveals Updated Data From IO102-IO103/Opdivo Combo Trial In Melanoma
IO Biotech Inc (NASDAQ: IOBT) 
BioNTech Posts Interim Phase 1 Data From CAR-T/Cancer Vaccine Combo In Solid Tumors
BioNTech SE (NASDAQ: BNTX) presented data from its ongoing Phase 1/2 trial of its CAR-T cell therapy candidate, BNT211, in advanced solid tumors. 
AIM ImmunoTech Shares Jump On Positive Data From Ampligen Study In Breast Cancer Setting
AIM ImmunoTech Inc (NYSE: AIM) has 
Zentalis Pharma Posts Initial Clinical Data On Its Wee1 Inhibitor In Ovarian Cancer
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) 
VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114
Seres Therapeutics Ditches Its SER-301 Phase 1b Second Study In Ulcerative Colitis
VBI Vaccines To Start Clinical Study Of Pan-Coronavirus Vaccine Candidate This Year
VBI Vaccines Inc (NASDAQ: VBIV) announced 
Stealth Bio's SBT-272 Shows Encouraging Action In Huntington's Disease Animal Model
Stealth BioTherapeutics Corp (NASDAQ: MITO) announced the presentation of 
Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients
Portage Biotech Inc (NASDAQ: PRTG) has updated its clinical development programs and announced its development goals for 2022, and it continues to work toward multiple clinical readouts in 2022.
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Longeveron Inc (NASDAQ: LGVN) announced the publication of Phase 1 trial results of Lomecel-B on patients with mild Alzheimer's disease (AD) in the Alzheimer's & Dementia journal.
CureVac - GSK Start Dosing In Next-Gen COVID-19 Vaccine Candidate Trial
Synthetic Biologics' VCN-01 Shows Favorable Safety Profile, Clinical Activity In Early-Stage Cancer Study
Synthetic Biologics Inc (NYSE: SYN) 
Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints
Biogen Inc (NASDAQ: BIIB) and Ionis Pharmaceuticals Inc (NASDAQ: IONS) have 
Pluristem's PLX-R18 Shows Meaningful Advantage Over Other Treatments In Transplant Patients
Aligos Pulls Plug On Early-Stage Chronic Hepatitis B Treatment Candidate
Aligos Therapeutics Inc (NASDAQ: ALGS) has 
Why ORIC Pharmaceuticals Shares Are Plunging Today
Terns Reports Topline Results from Early-Stage NASH Study
Terns Pharmaceuticals Inc (NASDAQ: TERN) 
Pulmatrix's COPD Candidate Shows Early Safety, Preliminary Pharmacokinetic Results